Company Search:
Advanced Search
Sponsored Links
Acerus Pharmaceuticals Corporation Company Snapshot
Acerus Pharmaceuticals Corporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acerus Pharmaceuticals with three other companies in this sector in Canada: Theratechnologies Inc. (2016 sales of 37.07 million Canadian Dollars [US$28.30 million] of which 100% was Therapeutic Peptides), Nuvo Pharmaceuticals Inc (27.04 million Canadian Dollars [US$20.64 million] ), and Cardiome Pharma Corp. (33.37 million Canadian Dollars [US$25.47 million] of which 100% was Pharma Product Development).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Acerus Pharmaceuticals Corporation
  Stock Performance Chart for Acerus Pharmaceuticals Corporation
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): .27
(Figures in Canadian Dollars)
1 Week 5.9%   13 Weeks -3.6%  
4 Weeks -15.6%   52 Weeks 145.5%  
Acerus Pharmaceuticals Corporation Key Data:
  Ticker: ASP Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 32,354,331
(Year Ending Jan 2017).
Employees: 17
  Currency: Canadian Dollars Market Cap: 57,542,034
  Fiscal Yr Ends: December Shares Outstanding: 213,118,645
  Share Type: Closely Held Shares: 127,550,329
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.